C12Y 306/04012
Dna helicase
Official title: DNA helicase (3.6.4.12)
C12Y306/04012 (Dna helicase) appears on 42 US grants and 95 published applications in this corpus.
Search patents in C12Y- Granted patents
- 42
- Published applications
- 95
- Assignees
- 58
- Inventors
- 231
- Latest grant
- 27 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 3 |
| 2015 | 0 | 2 |
| 2016 | 1 | 6 |
| 2017 | 0 | 4 |
| 2018 | 3 | 3 |
| 2019 | 4 | 6 |
| 2020 | 5 | 6 |
| 2021 | 4 | 12 |
| 2022 | 5 | 9 |
| 2023 | 3 | 9 |
| 2024 | 6 | 8 |
| 2025 | 8 | 19 |
| 2026 | 1 | 6 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Mesophilic argonaute systems and uses thereof27 Jan 2026US 12,534,499 B2Intima Bioscience, Inc.
- Compositions and methods for dissolving protein aggregates7 Oct 2025US 12,435,109 B2Rjk Biopharma Ltd.
- Multipart reagents having increased avidity for polymerase binding17 Jun 2025US 12,331,356 B2Element Biosciences, Inc.
- Modified helicases25 Mar 2025US 12,258,591 B2Oxford Nanopore Technologies PLC
- Modified helicases18 Mar 2025US 12,252,717 B2Oxford Nanopore Technologies PLC
- Strand Displacement-Based Gene Editing Method and System and Use Thereof17 Sep 2026US 2026/0275310 A1
- Helicase-cytidine deaminase complexes and methods of use27 Aug 2026US 2026/0250655 A1Illumina, Inc.
- Stable production systems for adeno-associated virus production16 Jul 2026US 2026/0201344 A1Asimov Inc.
- Helicase mutant, and preparation method therefor and use thereof in high-throughput sequencing16 Jul 2026US 2026/0201352 A1Bgi Hangzhou Cycloneseq Technology Co., Ltd.
- Improved system for producing rna-packaged aav particles9 Jul 2026US 2026/0193673 A1Huidagene Therapeutics (Singapore) Pte. Ltd.
Most cited
By later US patents
- Enzyme stalling method36US 10,221,450 B2Oxford Nanopore Technologies PLC · 2019
- Multipart reagents having increased avidity for polymerase binding31US 10,704,094 B1Element Biosciences, Inc. · 2020
- Multipart reagents having increased avidity for polymerase binding31US 10,982,280 B2Element Biosciences, Inc. · 2021
- Method for nanopore RNA characterisation19US 10,480,026 B2Oxford Nanopore Technologies PLC · 2019
- Method for nanopore RNA characterisation17US 11,021,747 B2Oxford Nanopore Technologies PLC · 2021